10
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Chemical Cleavage of Mismatches in Heteroduplexes of the rpoB Gene for Detection of Mutations Associated with Resistance of Mycobacterium tuberculosis to Rifampin

Pages 395-398 | Published online: 08 Jul 2009

  • Crofton J, Home N, Miller F. Clinical tuberculosis. London: Macmillan Education, 1992.
  • Kochi A, Vareldzis B, Styblo K. Multidrug-resistant tuberculosis and its control. Res Microbiol 1993; 144: 104–10.
  • Raviglione MC. Secular tends of tuberculosis in Western Europe. Bull World Health Organ 1993; 77: 21–43.
  • Cole ST. Mycobacterium tuberculosis: drug resistance mechanisms. Trends Microbiol 1994; 2: 411–5.
  • Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Golston MJ, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647–50.
  • Whelen AC, Felmlee TA, Hunt JM, Williams DL, Roberts GD, Stockman L, et al. Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR. J Clin Microbiol 1995; 33: 556–61.
  • Watterson SA, Wilson SM, Yates MD, Drobniewski FA. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998; 36: 1969–73.
  • Cotton RGH, Rodriges NR, Campbell RD. Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proc Natl Acad Sci USA 1988; 85: 4397–401.
  • Roberts RG, Bobrow M, Bentley DR. Point mutations in the dystrophin gene. Proc Natl Acad Sci USA 1992; 89: 2331–5.
  • Laszlo A, Rahman M, Raviglione M, Bustreo F. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD supranational laboratory network: first round of proficiency testing. Int J Tuberc Lung Dis 1997; 1: 231–8.
  • Kent PT, Kubica GP. Public health mycobacteriology, a guide for the level III laboratory. Atlanta. CDC, US Department of Health and Human Service Publication No. (CDC) 86–216546, 1985; 21–30.
  • Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1988; 85: 4397–401.
  • Cotton RG, Dahl HH, Forrest S, Howells DW, Ramus SJ, Bishop RE, et al. Analysis of sequence contexts flanking T.G mismatches leads to prediction about reactivity of the mismatched T to osmium tetroxide. DNA Cell Biol 1993; 12: 945–9.
  • Kim BJ, Kim SY, Park B-H, Liu M-A, Park I-K, Bai GH, et al. Mutations in the rpoB in Mycobacterium tuberculosis that interfere with PCR-single strand conformation polymorphism analysis for rifampin susceptibility testing. J Clin Microbiol 1997; 35: 492–4.
  • Michael D. Treatment of MDR-TB. N Engl J Med 1993; 99: 1–10.
  • Hansen LL, Justesen J, Kruse TA. Sensitive and fast mutation detection by solid phase chemical cleavage. Hum Mutat 1996; 7: 256–63.
  • Rowley G, Saad S, Giannelli F, Green PM. Ultrarapid mutation detection by multiplex, solid-phase chemical cleavage. Genomics 1995; 30: 574–82.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.